These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720 [TBL] [Abstract][Full Text] [Related]
5. A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia. Graham SH; Chen J; Lan JQ; Simon RP J Pharmacol Exp Ther; 1996 Jan; 276(1):1-4. PubMed ID: 8558416 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion. Graham SH; Chen J; Lan J; Leach MJ; Simon RP J Pharmacol Exp Ther; 1994 May; 269(2):854-9. PubMed ID: 7910213 [TBL] [Abstract][Full Text] [Related]
9. Early effects of GM1 in experimental cerebral focal ischemia in rabbits. Bo P; Marchioni E; Soragna D; Savoldi F Boll Soc Ital Biol Sper; 1993 Nov; 69(11):705-10. PubMed ID: 8060600 [TBL] [Abstract][Full Text] [Related]
10. Protection against Experimental Stroke by Ganglioside GM1 Is Associated with the Inhibition of Autophagy. Li L; Tian J; Long MK; Chen Y; Lu J; Zhou C; Wang T PLoS One; 2016; 11(1):e0144219. PubMed ID: 26751695 [TBL] [Abstract][Full Text] [Related]
11. A study of the dose dependency of a glycine receptor antagonist in focal ischemia. Chen J; Graham S; Moroni F; Simon R J Pharmacol Exp Ther; 1993 Nov; 267(2):937-41. PubMed ID: 8246170 [TBL] [Abstract][Full Text] [Related]
12. The dose-effectiveness of intranasal VEGF in treatment of experimental stroke. Yang JP; Liu HJ; Wang ZL; Cheng SM; Cheng X; Xu GL; Liu XF Neurosci Lett; 2009 Sep; 461(3):212-6. PubMed ID: 19559076 [TBL] [Abstract][Full Text] [Related]
13. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. Khan M; Sekhon B; Jatana M; Giri S; Gilg AG; Sekhon C; Singh I; Singh AK J Neurosci Res; 2004 May; 76(4):519-27. PubMed ID: 15114624 [TBL] [Abstract][Full Text] [Related]
14. Monosialoganglioside effects following cerebral ischemia: relationship with anti-neuronotoxic and pro-neuronotrophic effects. Lipartiti M; Seren MS; Lazzaro A; Koga T; Mazzari S; Facci L; Fusco M; Toffano G; Leon A Acta Neurobiol Exp (Wars); 1990; 50(4-5):489-94. PubMed ID: 2130663 [TBL] [Abstract][Full Text] [Related]
15. GM1 ganglioside inhibits ischemic release of amino acid neurotransmitters from rat cortex. Phillis JW; O'Regan MH Neuroreport; 1995 Oct; 6(15):2010-2. PubMed ID: 8580429 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models. Kohara A; Takahashi M; Yatsugi S; Tamura S; Shitaka Y; Hayashibe S; Kawabata S; Okada M Brain Res; 2008 Jan; 1191():168-79. PubMed ID: 18164695 [TBL] [Abstract][Full Text] [Related]
18. Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat. Stroemer RP; Rothwell NJ J Cereb Blood Flow Metab; 1997 Jun; 17(6):597-604. PubMed ID: 9236716 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of a standardized extract of Diospyros kaki leaves on MCAO transient focal cerebral ischemic rats and cultured neurons injured by glutamate or hypoxia. Bei W; Peng W; Zang L; Xie Z; Hu D; Xu A Planta Med; 2007 Jun; 73(7):636-43. PubMed ID: 17583826 [TBL] [Abstract][Full Text] [Related]
20. Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats. Westermaier T; Zausinger S; Baethmann A; Schmid-Elsaesser R Acta Neurochir (Wien); 2005 May; 147(5):525-32; discussion 532. PubMed ID: 15838594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]